Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Submitted by
admin
on June 29, 2012 - 10:21pm
Source:
Bloomberg
News Tags:
Amylin
Bristol-Myers Squibb
M&A
diabetes
Headline:
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Do Not Allow Advertisers to Use My Personal information
